INFORME RACIM. Actualización sobre medicamentos retirados por motivos de seguridad en otros países y su permanencia en Argentina

GLP-1 Receptor Agonists in Brazil: Landscape of Consumption, Safety and Regulation

Early Identification of Cardiovascular Adverse Events Associated With Rofecoxib Using Real‐World Data From the UK: A Nested Case–Control and Case‐Crossover Study

IMPLEMENTATION OF ACTIVE PHARMACOVIGILANCE SYSTEMS IN HEALTH SERVICES AND PHARMACEUTICAL INDUSTRIES: A CRITICAL ANALYSIS OF ANVISA’S REQUIREMENTS

Computational variant predictors for pharmacogenomics: from evaluation of single alleles to assessment of adverse drug reactions to antidepressants

Profeco y Cofepris alertan por comercialización ilegal de productos con Tirzepatida

FDA - Novo Nordisk Inc. – Warning Letter

FDA Launches New Adverse Event Look-Up Tool

Drug-associated Torsades de Pointes and QT Prolongation in Infants: A Focused Real-World Disproportionality Analysis Pharmacovigilance Study.

A multi-state cross-sectional assessment of essential medicine availability in Sudan during armed conflict

Señales de notificación desproporcionada de eventos supuestamente atribuibles a las vacunas contra la covid-19 en niños y adolescentes: estudio de casos/no casos, Brasil, 2022

Comparing infectious risk of Trastuzumab-deruxtecan to Trastuzumab-emtansine in patients with breast cancer

Building pharmacovigilance-ready datasets from resource-limited settings: Study of antiretroviral-associated ADRs in Melanesian patients

Reclaiming Pharmacovigilance: Bridging the Evidence–Practice Gap in Psychopharmacology

Data-driven medical devices and the EU MDR: mapping gaps in standards for regulatory compliance

FDA’s Regulatory Reforms to Unlock Competition and Lower Drug Costs Breaking the Biosimilar Bottleneck

Comparative Safety of Six First-Line Antiepileptic Monotherapies in Pediatric Epilepsy Using the United States FDA Adverse Event Reporting System

Surge el Centro Nacional de Farmacovigilancia y Tecnovigilancia (CENAFyT)

Long-term safety evaluation of mirtazapine: A real-world pharmacovigilance study based on the FAERS database

Data mining and analysis of adverse drug events of propofol in the general population and the elderly based on the US Food and Drug Administration Adverse Event Reporting System

La AEMPS publica el Informe Anual sobre Farmacovigilancia Veterinaria

“Is This Normal?”: Understanding and Managing Adverse Reactions

Two deaths reported to drug watchdog over potential link to weight-loss jabs

OTC Medications Expose Toddlers to Potentially Risky Parabens

Reducing drug failures with AI, human liver organoids

Perspectiva de género en problemas asociados a medicamentos de alto riesgo atendidos en urgencias

Secular Trends in the Use of Valproate-Containing Medicines in Women of Childbearing Age in Europe: A Multinational DARWIN EU Network Study

Detection of Illicit Content on Online Marketplaces using Large Language Models

Adverse events and potential herb-drug interactions of plants used for psoriasis: A systematic review

Is intramuscular adrenaline used promptly against drug-induced anaphylaxis? A perspective from recent analyses of fatal cases in Japan

Relationship Between Trimethoprim-Sulfamethoxazole-Induced Hepatotoxicity and Cytochrome Protein 450 2C9 Using Food and Drug Administration Adverse Event Reporting System Database

Counterfeit Medicines in Informal Retail: A Governance and Complexity Perspective from South African Spaza Shops

Precision Pharmacotherapy and the Artificial Intelligence Revolution in the Neonatal Intensive Care Unit: Developmental Pharmacology, Drug Safety, and Generative Redesign

ChatGPT as a Tool for Perioperative Safety: Evaluating Drug Interaction Detection in Anesthetic Regimens

PERFIL EPIDEMIOLÓGICO E CLÍNICO DAS NOTIFICAÇÕES RELACIONADAS AOS EVENTOS ADVERSOS À TOXINA BOTULÍNICA NO BRASIL: UMA ANÁLISE DE DADOS DO VIGIMED (2018–2025)

Disproportionality Analysis and Timing of Drug-Induced Guillain–Barré Syndrome Onset Based on the Japanese Adverse Drug Adverse Event Report Database

Prevalence of potentially inappropriate medication prescribing, inappropriate medication use, prescription omission and drug interactions among older adults in Ethiopia: a systematic review and meta-analysis

Managing High‐Risk Drug Interactions With Nirmatrelvir/Ritonavir: Experience From a Dedicated Pharmacology Advice Service

AI-Driven ADE: Detection and Clinician-Readable Explanation of Adverse Drug Events in Open Clinical

Exploring Drug Safety Through Knowledge Graphs: Protein Kinase Inhibitors as a Case Study